Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14)

被引:76
|
作者
Covington, MD
Burghardt, RC
Parrish, AR
机构
[1] Texas A&M Univ, Coll Med, Dept Med Pharmacol & Toxicol, Syst Hlth Sci Ctr, College Stn, TX USA
[2] Texas A&M Univ, Coll Vet Med, Dept Vet Integrated Biosci, College Stn, TX USA
关键词
shRNA; acute renal failure; proximal tubules;
D O I
10.1152/ajprenal.00179.2005
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Renal Physiol 290: F43-F51, 2006. First published August 2, 2005; doi:10.1152/ajprenal.00179.2005.- Ischemia is a leading cause of acute renal failure (ARF), a disease associated with high morbidity and mortality. Disruption of intercellular adhesion in the proximal tubules is linked to ARF, although the molecular mechanism(s) remains unclear. Our previous studies showed that ischemia is associated with cadherin cleavage and loss in NRK cells, putatively due to a matrix metalloproteinase (MMP) (7). In the current studies, a MMP required for E-cadherin cleavage and N-cadherin loss was identified. Chemical inhibitors against a number of soluble MMPs ( 1, 2, 3, 8, 9) failed to completely attenuate ischemia-induced cadherin loss. Under ischemic conditions, there was an increase in active membrane-type (MT) 1-MMP but a decrease in MMP-2 protein expression. Plating cells on fibronectin protected against ischemia-induced loss of cadherins and, interestingly, no increase in active MT1-MMP levels was seen in ischemic cells on fibronectin-coated dishes. In addition, L cells stably expressing E- (LE) or N- cadherin (LN), but lacking MT1-MMP expression, were resistant to ischemia-induced cadherin loss. The role of MT1-MMP in ischemia-induced cadherin loss was confirmed by either blocking MT1-MMP activity with a neutralizing antibody or expression with shRNA constructs which protected full-length E- and N- cadherin during ischemia. Using shRNA constructs to suppress MT1-MMP expression, ischemia-induced disruption of cadherin function was ablated, and cell-cell contacts were preserved. These results demonstrate that ischemia induces increased expression of active MT1-MMP and subsequent disruption of cadherin/catenin complexes, implying that MT1-MMP plays a role in ischemia-induced ARF.
引用
收藏
页码:F43 / F51
页数:9
相关论文
共 50 条
  • [1] Ischemia-induced cleavage of cadherins in NRK cells: evidence for a role of metalloproteinases
    Covington, MD
    Bayless, KJ
    Burghardt, RC
    Davis, GE
    Parrish, AR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (02) : F280 - F288
  • [2] Ischemia-induced cleavage of Cadherins in NRK cells is not sufficient for β-catenin transcriptional activity
    Chen, Gang
    Akintola, Adebayo D.
    Catania, Jeffrey M.
    Covington, Marisa D.
    Dean, Dana D.
    Trzeciakowski, Jerome P.
    Burghardt, Robert C.
    Parrish, Alan R.
    [J]. CELL COMMUNICATION AND ADHESION, 2007, 14 (04): : 111 - 123
  • [3] Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas
    Ye, HQQ
    Maeda, M
    Yu, FSX
    Azar, DT
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (10) : 2894 - 2899
  • [4] Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers
    Kerkelä, E
    Ala-aho, R
    Jeskanen, L
    Lohi, J
    Grénman, R
    Kähäri, VM
    Saarialho-Kere, U
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (05) : 659 - 669
  • [5] Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers
    E Kerkelä
    R Ala-aho
    L Jeskanen
    J Lohi
    R Grénman
    V M-Kähäri
    U Saarialho-Kere
    [J]. British Journal of Cancer, 2001, 84 : 659 - 669
  • [6] MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas
    Ren, Yin
    Hyakusoku, Hiroshi
    Sagers, Jessica E.
    Landegger, Lukas D.
    Welling, D. Bradley
    Stankovic, Konstantina M.
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [7] Increased serum level of membrane type 1-matrix metalloproteinase (MT1-MMP/MMP-14) in patients with breast cancer
    Laudanski, P.
    Swiatecka, J.
    Kozlowski, L.
    Lesniewska, M.
    Wojtukiewicz, M.
    Wolczynski, S.
    [J]. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (01) : 101 - 103
  • [8] Synthesis and in vitro evaluation of 68Ga-labeled peptides for metalloproteinase (MT1-MMP/MMP-14) targeting on HT1080 cells
    Liolios, C.
    Bauder-Wuest, U.
    Schaefer, M.
    Kopka, K.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S522 - S522
  • [9] Cellular mechanisms for human procollagenase-3 (MMP-13) activation - Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme
    Knauper, V
    Will, H
    LopezOtin, C
    Smith, B
    Atkinson, SJ
    Stanton, H
    Hembry, RM
    Murphy, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (29) : 17124 - 17131
  • [10] A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1-MMP
    Shiryaev, S. A.
    Remacle, A. G.
    Golubkov, V. S.
    Ingvarsen, S.
    Porse, A.
    Behrendt, N.
    Cieplak, P.
    Strongin, A. Y.
    [J]. ONCOGENESIS, 2013, 2 : e80 - e80